Rey G, Jougla E. Are alcohol-attributable mortality estimates reliable? Eur J Public Health. 2014 Feb;24(1):3–4.
Viallon V, Banerjee O, Jougla E, Rey G, Coste J. Empirical comparison study of approximate methods for structure selection in binary graphical models. Biom J. 2014 Mar;56(2):307–31.
Saucedo M, Bouvier-Colle M-H, Chantry AA, Lamarche-Vadel A, Rey G, Deneux-Tharaux C. Pitfalls of national routine death statistics for maternal mortality study. Paediatr Perinat Epidemiol. 2014 Nov;28(6):479–88.
Lefeuvre D, Pavillon G, Aouba A, Lamarche-Vadel A, Fouillet A, Jougla E, et al. Quality comparison of electronic versus paper death certificates in France, 2010. Popul Health Metr. 2014;12(1):3.
Romon I, Rey G, Mandereau-Bruno L, Weill A, Jougla E, Eschwège E, et al. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort. Diabet Med. 2014 Aug;31(8):946–53.
Bouvier A-M, Remontet L, Jougla E, Launoy G, Grosclaude P, Buémi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877–81.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004 Jul 15;101(2):317–24.
Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590–8.
Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski J-P, Ganne N, Hillon P, et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol. 2008 Feb;48(2):200–7.
Ziadé N, Jougla E, Coste J. Population-level influence of rheumatoid arthritis on mortality and recent trends: a multiple cause-of-death analysis in France, 1970-2002. J Rheumatol. 2008 Oct;35(10):1950–7.
Romon I, Jougla E, Balkau B, Fagot-Campagna A. The burden of diabetes-related mortality in France in 2002: an analysis using both underlying and multiple causes of death. Eur J Epidemiol. 2008;23(5):327–34.
Benhamou D, Lienhart A, Auroy Y, Péquignot F, Jougla E. Accidents by ABO incompatibility and other main complications related to blood transfusion in surgical patients: data from the French national survey on anaesthesia-related deaths. Transfus Clin Biol. 2005 Nov;12(5):389–90.
Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005 Feb;34(1):121–30.
Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005 Jun;42(6):799–805.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis. 2005;37(6–7):482–7.